Abiraterone is a potent, selective, and irreversible inhibitor of cytochrome P-450c17 (CYP17A1), a key enzyme in the steroidogenesis pathway that plays a crucial role in the adrenal glands, testes, and prostate cancer cells [2]. Here, CYP17A1 is linked to prostate cancer.